Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Usher syndrome in Denmark: mutation spectrum and some clinical observations

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Dentinogenesis imperfecta type II- genotype and phenotype analyses in three Danish families

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The pathogenicity of genetic variants previously associated with left ventricular non-compaction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. MT-CYB mutations in hypertrophic cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Functional Assessment of Variants Associated with Wolfram Syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association of SLC26A4 mutations, morphology, and hearing in pendred syndrome and NSEVA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

BACKGROUND: Usher syndrome (USH) is a genetically heterogeneous deafness-blindness syndrome, divided into three clinical subtypes: USH1, USH2 and USH3.

METHODS: Mutations in 21 out of 26 investigated Danish unrelated individuals with USH were identified, using a combination of molecular diagnostic methods.

RESULTS: Before Next Generation Sequencing (NGS) became available mutations in nine individuals (1 USH1, 7 USH2, 1 USH3) were identified by Sanger sequencing of USH1C,USH2A or CLRN1 or by Arrayed Primer EXtension (APEX) method. Mutations in 12 individuals (7 USH1, 5 USH2) were found by targeted NGS of ten known USH genes. Five novel pathogenic variants were identified. We combined our data with previously published, and obtained an overview of the USH mutation spectrum in Denmark, including 100 unrelated individuals; 32 with USH1, 67 with USH2, and 1 with USH3. Macular edema was observed in 44 of 117 individuals. Olfactory function was tested in 12 individuals and found to be within normal range in all.

CONCLUSION: Mutations that lead to USH1 were predominantly identified in MYO7A (75%), whereas all mutations in USH2 cases were identified in USH2A. The MYO7A mutation c.93C>A, p.(Cys31*) accounted for 33% of all USH1 mutations and the USH2A c.2299delG, p.(Glu767Serfs*21) variant accounted for 45% of all USH2 mutations in the Danish cohort.

OriginalsprogEngelsk
TidsskriftMolecular Genetics & Genomic Medicine
Vol/bind4
Udgave nummer5
Sider (fra-til)527-539
Antal sider13
ISSN2324-9269
DOI
StatusUdgivet - sep. 2016

ID: 49586733